(Q37067589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Omer Dizdar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sercan Aksoy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hakan Harputluoglu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Saadettin Kilickap

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ibrahim Barista

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

23 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

381-385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18221389%20AND%20SRC:MED&resulttype=core&format=json

HCV and non-Hodgkin lymphoma

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Reactivation of hepatitis C virus after chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Effects of corticosteroids on HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X

Long-term outcome of hepatitis C infection after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01039.X